@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@tech.eu 3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@techcrunch.com 4 years ago
DNA Script picks up $38.5 million to make DNA production faster and simpler
@extremetech.com 6 years ago
23andMe, Michael J. Fox Foundation to Study Genetic Factors of Parkinson’s
@techcrunch.com 6 years ago
Genoox raises $6M to make genetic data analysis more accessible for clinics
@theverge.com 9 years ago
White House unveils $215 million plan to develop patient-specific medical treatments
@theverge.com 9 years ago
23andMe to offer users' medical data to Pfizer for research